// App-Quantinova.ai

: Alveolar type II cells harbouring SARS-CoV-2 show senescence with a proinflammatory phenotype

Researchers

Presenter

  • Koralia Paschalaki

Principal Investigators

  • Konstantinos Evangelou

  • Dimitris Veroutis

  • Periklis Foukas

  • Christos Kittas

  • Athanasios Tzioufas

  • Laurence De Leval

  • Demetris Vassilakos

  • Peter Barnes

  • Vassilis Gorgoulis

Medical Centers

  • National Heart and Lung Institute, Imperial College London, London, United Kingdom

  • Lausanne University Hospital, Lausanne, Switzerland

  • National and Kapodistrian University of Athens, Athens, Greece

Locations

  • Greece

  • United Kingdom

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Coronavirus disease

Biomarkers

  • Transcription termination factor 1

  • Interleukin 6

  • Interleukin 1 beta

Drug/Treatment

  • Sulfasalazine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved